MannKind gets FDA approval for inhaled insulin in children ages 6 and up

May 29, 2026 12:30 PM

MannKind Corporation (NASDAQ: MNKD) announced the U.S. Food and Drug Administration approved Afrezza inhaled insulin for children and adolescents aged ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found